Search Within

Alexander Noor Shoushtari

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (28)
  3. Research Letter (5)
  4. Review (1)
Groups
  1. Department of Medicine (67)
  2. Epidemiology and Biostatistics (67)
  3. Hematologic Malignancies, Division of (67)
  4. Melanoma Disease Management Team (67)
  5. Melanoma and Immunotherapeutics Service (67)
  6. Solid Tumor Oncology Division (67)

More Groups

People
  1. Michael Postow (40)
  2. Katherine Panageas (34)
  3. Paul Chapman (32)
  4. Jedd Wolchok (31)
  5. Margaret Callahan (28)
  6. Parisa Momtaz (23)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Clinical Cancer Research (4)
  3. JAMA Oncology (4)
  4. Annals of Surgical Oncology (3)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (6)
  4. Springer (6)
  5. American Medical Association (4)
  6. Elsevier Inc. (4)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
    Journal Article

    Yang, C.; Sanchez-Vega, F.; Chang, J. C.; Chatila, W. K.; Shoushtari, A. N.; Ladanyi, M.; Travis, W. D.; Busam, K. J.; Rekhtman, N.
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma
    Journal Article

    Postow, M. A.; Knox, S. J.; Goldman, D. A.; Elhanati, Y.; Mavinkurve, V.; Wong, P.; Halpenny, D.; Reddy, S. K.; Vado, K.; McCabe, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade
    Journal Article

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K. S.; Hayes, S. A.; Bajwa, R.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas
    Meeting Abstract

    Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy
    Journal Article

    Umemura, Y.; Wang, D.; Peck, K. K.; Flynn, J.; Zhang, Z.; Fatovic, R.; Anderson, E. S.; Beal, K.; Shoushtari, A. N.; Kaley, T.; more...
    Journal of Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors
    Journal Article

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; Tixier, F.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save